Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03950986 · ClinicalTrials.gov registry record · NA

Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System

A NA study, sponsored by Atlanta VA Medical Center.

Completed
Registry status
NA
Development phase
67,000
Enrollment target

NCT03950986: Completed NA study, sponsored by Atlanta VA Medical Center.

NCT03950986 is a NA study that has completed, run by Atlanta VA Medical Center. The registered enrollment target is 67,000 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (4679% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03950986, a NA study, has completed, sponsored by Atlanta VA Medical Center.

COMPLETED
Registry status
NA
Development phase
67,000 participants
Enrollment target

Study Summary

The Office of Evaluation Sciences is collaborating with Emory University and the Atlanta VA Health Care System to increase adult immunizations uptake among veterans. The intervention targets patients of primary care providers (physicians, physician assistants and nurse practitioners) through a modification of the existing reminders in the VA electronic health record system. The team will evaluate the intervention using a randomized controlled trial.

Primary Outcome

Percent of patients receiving of one or more of the influenza, pneumococcal (PCV13 or PPSV23) or Tdap/Td vaccines during the observation period, conditional on the patient being due for at least one of these vaccines at any appointment during the observation period

Interventions

  • OTHER Modified clinical reminders

Trial Details

FieldValue
Enrollment Target 67,000 participants
Start Date 2018-10-15
Est. Completion 2019-06-30
Phase NA
Atlanta VA Medical Center

12 total trials

What the finished NCT03950986 record still lists

NCT03950986 is an interventional study that assigns participants to a tested intervention. Its 67,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (4679% higher).

The record links to 0 conditions, and to 1 intervention - of which Modified clinical reminders is the first listed.

NCT03950986 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03950986 about?

NCT03950986 is a clinical study titled "Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System". The Office of Evaluation Sciences is collaborating with Emory University and the Atlanta VA Health Care System to increase adult immunizations uptake among veterans. The intervention targets patients of primary care providers (physicians, physician assistants and nurse practitioners) through a modif...

What is the current status of trial NCT03950986?

This trial is currently completed. It is a NA study. The enrollment target is 67,000 participants. The study started on 2018-10-15. Estimated completion is 2019-06-30.

What interventions are being tested in trial NCT03950986?

The interventions under investigation include: Modified clinical reminders (OTHER).

Who is sponsoring clinical trial NCT03950986?

This trial is sponsored by Atlanta VA Medical Center, which has 12 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03950986's enrollment target sits among peer trials

67,000 4th of 2000 higher than 1,997 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00009633 · 68,000 participants

    Follow-up Visit of High Risk Infants

  • NCT06903897 · 68,000 participants · NA

    Social Needs Screening and Chronic Diseases Study (WE CARE)

  • NCT04473833 · 65,000 participants · NA

    Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer

  • NCT05128006 · 63,200 participants

    Direct-to-patient Teledermatology and Computer-assisted Diagnosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03950986, the US trial registry maintained by the National Library of Medicine. NCT03950986 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.